Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Clumeck

Showing results (161-170 of 191) with videos related to

Pageof 20
Sort By:
AIDS (London, England)|June 1, 1988
Human immunodeficiency virus transmission among heterosexual couples in Central AfricaM Carael, P H Van de Perre, P H Lepage, et al.
The Journal of Hospital Infection|June 29, 2020
Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staffC Martin, I Montesinos, N Dauby, et al.
AIDS (London, England)|July 1, 1996
Epidemiology of AIDS-related Kaposi's sarcoma in Europe over 10 years. AIDS in Europe Study GroupP Hermans, J Lundgren, B Sommereijns, et al.
HIV Medicine|March 14, 2007
Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or deathC Holkmann Olsen, A Mocroft, O Kirk, et al.
Lancet (London, England)|October 4, 1986
Predicting gentamicin resistance from annual usage in hospitalH Goossens, G Ghysels, Y Van Laethem, et al.
JAMA|April 13, 1994
Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study GroupJ D Lundgren, A N Phillips, C Pedersen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2000
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survivalA Mocroft, S Madge, A M Johnson, et al.
Dermatologica|January 1, 1984
[Acquired immunodeficiency syndrome (AIDS) manifested as severe genital herpes. Apropos of 2 cases]J De Maubeuge, F Mascart-Lemone, N Clumeck, et al.
AIDS (London, England)|March 1, 1994
Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017)J W Mulder, D A Cooper, L Mathiesen, et al.
AIDS (London, England)|August 1, 1991
The efficacy and safety of zidovudine with or without acyclovir in the treatment of patients with AIDS-related complex. The European-Australian Collaborative GroupD A Cooper, C Pedersen, F Aiuti, et al.
Pageof 20

Showing results (161-170 of 191) with videos related to

Sort By:
Pageof 20
AIDS (London, England)|June 1, 1988
Human immunodeficiency virus transmission among heterosexual couples in Central AfricaM Carael, P H Van de Perre, P H Lepage, et al.
The Journal of Hospital Infection|June 29, 2020
Dynamics of SARS-CoV-2 RT-PCR positivity and seroprevalence among high-risk healthcare workers and hospital staffC Martin, I Montesinos, N Dauby, et al.
AIDS (London, England)|July 1, 1996
Epidemiology of AIDS-related Kaposi's sarcoma in Europe over 10 years. AIDS in Europe Study GroupP Hermans, J Lundgren, B Sommereijns, et al.
HIV Medicine|March 14, 2007
Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or deathC Holkmann Olsen, A Mocroft, O Kirk, et al.
Lancet (London, England)|October 4, 1986
Predicting gentamicin resistance from annual usage in hospitalH Goossens, G Ghysels, Y Van Laethem, et al.
JAMA|April 13, 1994
Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study GroupJ D Lundgren, A N Phillips, C Pedersen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 14, 2000
A comparison of exposure groups in the EuroSIDA study: starting highly active antiretroviral therapy (HAART), response to HAART, and survivalA Mocroft, S Madge, A M Johnson, et al.
Dermatologica|January 1, 1984
[Acquired immunodeficiency syndrome (AIDS) manifested as severe genital herpes. Apropos of 2 cases]J De Maubeuge, F Mascart-Lemone, N Clumeck, et al.
AIDS (London, England)|March 1, 1994
Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017)J W Mulder, D A Cooper, L Mathiesen, et al.
AIDS (London, England)|August 1, 1991
The efficacy and safety of zidovudine with or without acyclovir in the treatment of patients with AIDS-related complex. The European-Australian Collaborative GroupD A Cooper, C Pedersen, F Aiuti, et al.
Pageof 20